The FDA has cleared its first automated insulin pump for adults with Type 2 diabetes, with Insulet’s Omnipod 5 delivery system opening the door to a population of more than 6 million people.

By pairing Insulet’s Omnipod 5 pump with a continuous glucose monitor, the device will automatically adjust insulin delivery based on a person’s blood glucose levels. Insulet’s new ...

Embecta’s FDA green light comes shortly after the agency’s first clearance for an automated insulin pump in Type 2 diabetes, with Insulet’s tubeless, patch-based Omnipod 5.

The U.S. Food and Drug Administration has approved the first-ever device that provides automated insulin dosing for people with type 2 diabetes. The U.S. Food and Drug Administration has approved ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its groundbreaking Omnipod 5 Automated Insulin Delivery System ...

developed a small pump device worn directly on the body rather than using tubing. FDA first cleared an Omnipod Insulin Management System in 2003, which didn't include a continuous monitoring system.

Recommended Reading Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes Insulet received Food and Drug Administration clearance on Monday for its newest insulin pump to be used by ...

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today ...

August 26, 2024--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today ...